For immediate release: January 13, 2022 Boston, MA – Multiple sclerosis (MS), a progressive disease that affects 2.8 million people worldwide and for which there … Continue reading “Epstein-Barr virus may be leading cause of multiple sclerosis”
For immediate release: January 12, 2022 Boston, MA – People who consume higher amounts of olive oil may lower their risk of premature death … Continue reading “Higher olive oil consumption linked with lower risk of premature death”
Certain groups in the U.S.—Blacks, Asians, Hispanics, Latinos, and low-income populations—are being exposed to higher levels of dangerous fine particulate air pollution than other groups, a study found.
Decreasing vehicle emissions since 2008 have reduced by thousands the number of deaths attributable to air pollution, yielding billions of dollars in benefits to society, according to a new study led by Harvard Chan School researchers.
For immediate release: Wednesday, December 8, 2021 Boston, MA – A newly discovered hormone named fabkin helps regulate metabolism and may play an important … Continue reading “Newly identified hormone may be a critical driver of type 1 and type 2 diabetes”
Harvard T.H. Chan School of Public Health and Vanke School of Public Health, Tsinghua University, today announced the launch of a collaboration on educational and research initiatives.
Both vaccines are highly effective and either one is strongly recommended For immediate release: Wednesday, December 1, 2021 Boston, MA – Compared with … Continue reading “Moderna vaccine slightly more effective than Pfizer vaccine in preventing COVID-19 infection, hospitalization, and death”
For immediate release: Wednesday, December 1, 2021 Boston, MA – People who are vaccinated for SARS-CoV-2 but get breakthrough infections may be less likely … Continue reading “Breakthrough SARS-CoV-2 cases clear more quickly, less likely to spread infection over time”
Delta-like SARS-CoV-2 variants are most likely to increase pandemic severity, according to a new study.
Harvard Chan School and the Second Affiliated Hospital, Zhejiang University School of Medicine in Hangzhou, China, announce collaborative program in clinical research.
